ライフサイエンスコーパス: waist-to-hip ratio

1 height, weight, waist and hip circumference, waist-to-hip ratio).

2 vity Scale for the Elderly (PASE) score, and waist to hip ratio.

3 ist circumference, and 1.12 (1.08-1.15) with waist-to-hip ratio.

4 th waist circumference, body mass index, and waist-to-hip ratio.

5 BMI did not change the associations seen for waist-to-hip ratio.

6 smoking, triglycerides, body mass index, and waist-to-hip ratio.

7 0 (95% CI: 1.1, 3.6; p for trend = 0.03) for waist-to-hip ratio.

8 by the square of the height in meters), and waist-to-hip ratio.

9 tions were independent of age, sex, BMI, and waist-to-hip ratio.

10 tolic and diastolic blood pressure, BMI, and waist-to-hip ratio.

11 orced expiratory volume, blood pressure, and waist-to-hip ratio.

12 bolic traits such as lower triglycerides and waist-to-hip ratio.

13 ercent of body fat, waist circumference, and waist-to-hip ratio.

14 : 1.28 to 1.64, p < 0.001) when adjusted for waist-to-hip ratio.

15 , systolic and diastolic blood pressure, and waist-to-hip ratio.

16 size (women only), waist circumference, and waist-to-hip ratio.

17 rom the UK10K, testing for associations with waist-to-hip ratios.

18 67, 0.641] 50% vs. 50%; P = 2E-6) and higher waist-to-hip ratio (0.0013 [0.0003, 0.0024] 50% vs. 50%;

19 o 0.15), bodyweight (1.03 kg, 0.24 to 1.82), waist-to-hip ratio (0.006, 0.003 to 0.010), and an odds

20 1 y and 9 mo was the strongest predictor of waist-to-hip ratio (0.51; 95% CI: 0.00, 1.02; P = 0.05).

21 for waist circumference (0.86, 0.83-0.89) or waist-to-hip ratio (0.63, 0.57-0.70).

22 to-height ratio (0.82 [0.70-0.95]), elevated waist-to-hip ratio (0.79 [0.68-0.91]), and reduced HDL c

23 est quintile of intake; P for trend = 0.06), waist-to-hip ratio (0.92 and 0.91, respectively; P for t

24 Children with psoriasis had higher waist-to-hip ratios (0.85 vs. 0.80; P < 0.002) and insul

25 ), or for body fat (-0.80% [-1.80 to 0.21]), waist-to-hip ratio (-0.00 ratio [-0.01 to 0.00]), or lea

26 avorable body fat distribution, with a lower waist-to-hip ratio (-0.004 cm [95% CI -0.005, -0.003] 50

27 t two tertiles vs highest tertile of mAHEI), waist-to-hip ratio (1.44, 1.27-1.64 for highest vs lowes

28 ), PASE score, 3.3% (95% CI, 1.4%-6.8%), and waist to hip ratio, 1.6% (95% CI, 0.4%-3.7%).

29 ex 33.8%; low-density lipoprotein 31.4%; and waist-to-hip ratio 29.7%.

30 ated with increased body mass index-adjusted waist-to-hip ratio, act to specifically increase RSPO3 e

31 We analyze body mass index (BMI) and waist to hip ratio adjusted for BMI (WHRadjBMI) in the U

32 S) using variants previously associated with waist-to-hip ratio adjusted for BMI (WHRadjBMI) and exam

33 nd central body fat distribution measured as waist-to-hip ratio adjusted for BMI (WHRadjBMI) with 210

34 enetic risk scores for higher BMI and higher waist-to-hip ratio adjusted for BMI (WHRadjBMI) with cha

35 A genetic predisposition to higher waist-to-hip ratio adjusted for BMI (WHRadjBMI), a measu

36 ndividuals to identify genes associated with waist-to-hip ratio adjusted for BMI (WHRadjBMI), a surro

37 ndex (BMI), waist circumference (WC), or the waist-to-hip ratio adjusted for BMI (WHRBMI), the follow

38 e observe an association with increased BMI, waist-to-hip ratio adjusted for BMI is reduced, bioimped

39 In total, 20 of the 49 waist-to-hip ratio adjusted for BMI loci show significan

40 CI 0.037, 0.086; P = 8.1 x 10(-7)) but lower waist-to-hip ratio adjusted for BMI, a marker of abdomin

41 for association with body mass index (BMI), waist-to-hip ratio adjusted for BMI, and body fat percen

42 a genetic predisposition score including the waist-to-hip ratio adjusted for BMI-associated single nu

43 ith both endometriosis and fat distribution (waist-to-hip ratio adjusted for BMI; WHRadjBMI) in an in

44 We identify 49 loci (33 new) associated with waist-to-hip ratio adjusted for body mass index (BMI), a

45 cumference adjusted for body mass index" to "waist-to-hip ratio adjusted for body mass index (under 5

46 We identified 16 variants for waist-to-hip ratio adjusted for body mass index (WHRadjB

47 st causal associations of central adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjB

48 A genetic predisposition to higher waist-to-hip ratio adjusted for body mass index was asso

49 iation of body-fat distribution, assessed by waist-to-hip ratio adjusted for body mass index, with 22

50 ominal obesity, which can be measured as the waist-to-hip ratio adjusted for the body mass index (WHR

51 ist circumference, and 1.25 (1.19-1.31) with waist-to-hip ratio, after adjustment for age, sex, and s

52 nopause, body mass index (BMI), BMI-adjusted waist-to-hip ratio, alcohol intake, and tobacco smoking.

53 No difference was observed in waist-to-hip ratio, although the subscapular-to-triceps

54 We observed similar results in waist-to-hip ratio analyses.

55 lyses were conducted to evaluate the role of waist to hip ratio and body mass index in this associati

56 line after adjustment for sociodemographics, waist to hip ratio and conventional cardiovascular risk

57 body mass index (BMI), waist circumference, waist to hip ratio and fasting insulin.

58 ndelian randomization (MR) and data from 394 waist-to-hip ratio and 773 BMI-associated loci.

59 ronger genetic correlations than in men with waist-to-hip ratio and anorexia nervosa.

60 BP, chi-squared values for associations for waist-to-hip ratio and BMI fell by 56%.

61 chi-squared values for genetically-predicted waist-to-hip ratio and BMI models, respectively.

62 pants were used to estimate the relevance of waist-to-hip ratio and body mass index (BMI) to CKD prev

63 y mass index (BMI), waist circumference, and waist-to-hip ratio and diverticulitis and diverticular b

64 Each 0.06 higher measured waist-to-hip ratio and each 5-kg/m(2) increase in BMI we

65 Parkinson's disease, glycine, xanthine with waist-to-hip ratio and ergothioneine with inflammatory b

66 in resistance-related phenotype (e.g. higher waist-to-hip ratio and fasting insulin levels, but lower

67 with indexes of JNK signaling activity, IL6, waist-to-hip ratio and hsCRP.

68 1 cm decrease in height, a 0.003 increase in waist-to-hip ratio and increase in BMI by 0.14 kg/m(2) f

69 unction variants are associated with a lower waist-to-hip ratio and protection from type 2 diabetes.

70 ducational level, zygosity and chorionicity, waist-to-hip ratio and smoking.

71 Waist-to-hip ratio and the fasting insulin resistance in

72 Waist-to-hip ratio and the ratio of visceral to total ab

73 res including body fat, waist circumference, waist-to-hip ratio and triglycerides were significant on

74 on studies, including large meta-analysis of waist-to-hip ratio and waist circumference adjusted for

75 ndex [BMI], height, waist circumference, and waist-to-hip ratio) and body fat composition (total body

76 higher waist circumference, and 0.083 higher waist-to-hip ratio) and measures of risk discrimination

77 dy fat distribution (waist circumference and waist-to-hip ratio), and body composition (percent body

78 iabetes diagnosis, BMI, waist circumference, waist-to-hip ratio, and amount of European admixture.

79 sting glucose concentration, bodyweight, and waist-to-hip ratio, and an increased risk of type 2 diab

80 sting glucose concentration, bodyweight, and waist-to-hip ratio, and an increased risk of type 2 diab

81 ody mass index, hip and waist circumference, waist-to-hip ratio, and bioelectrical impedance-derived

82 e 2 diabetes diagnosis, waist circumference, waist-to-hip ratio, and BMI.

83 Elevated body mass index (BMI), higher waist-to-hip ratio, and body dissatisfaction have been i

84 ight, height, waist size, hip circumference, waist-to-hip ratio, and body mass index.

85 physical activity, smoking, marital status, waist-to-hip ratio, and dietary energy intake, individua

86 nts of body mass index, waist circumference, waist-to-hip ratio, and fat percentage through bioimpeda

87 se A positivity, and the interaction of age, waist-to-hip ratio, and length of the Barrett's oesophag

88 le fractions were greatest for hypertension, waist-to-hip ratio, and myocardial infarction.

89 ause, breastfeeding, age at first livebirth, waist-to-hip ratio, and oral contraceptive use did not d

90 ome-wide association studies (GWAS) for BMI, waist-to-hip ratio, and other adiposity traits have iden

91 influences of gender, body mass index (BMI), waist-to-hip ratio, and other variables.

92 ith fat mass, left ventricular mass, leptin, waist-to-hip ratio, and phosphocreatine/ATP ratio.

93 etween abdominal obesity, as measured by the waist-to-hip ratio, and plasma ascorbic acid concentrati

94 , body mass index, anorexia nervosa subtype, waist-to-hip ratio, and serum cortisol and leptin levels

95 Significant variables were insulin levels, waist-to-hip ratio, and smoking.

96 analysis on body mass index, height, weight, waist-to-hip ratio, and waist and hip circumference.

97 tudies, estimates of obesity (including BMI, waist-to-hip ratio, and waist circumference) were positi

98 s of central adiposity (waist circumference, waist-to-hip ratio, and waist-to-height ratio) and hyper

99 t circumference (WC), waist-to-height ratio, waist-to-hip ratio, and WC z score.

100 e consecutive age intervals; waist, hip, and waist-to-hip ratio; and height at age 18 years.

101 bles (including BMI, neck circumference, and waist-to-hip ratio), as well as for alcohol intake and s

102 associations of abdominal circumference and waist-to-hip ratio, as measures of abdominal adiposity,

103 h percentiles of body mass index, height and waist-to-hip ratio, as well as clinical classes of obesi

104 We found that several waist-to-hip ratio-associated variants map within primat

105 as body fat percentage, waist circumference, waist-to-hip ratio, basal metabolic rate, and fasting in

106 glucose, HbA1c, fasting insulin, bodyweight, waist-to-hip ratio, BMI, and risk of type 2 diabetes, us

107 ry, family breast cancer, physical activity, waist-to-hip ratio, body mass index, age at menarche, an

108 ondary outcomes, including apolipoprotein B, waist-to-hip ratio, body mass index, and 233 metabolic b

109 iposity, measured as waist circumference and waist-to-hip ratio both adjusted for BMI.

110 anges were associated with a decrease in the waist-to-hip ratio but no significant change in fasting

111 cardiovascular/metabolic disease, and higher waist-to-hip ratio, but also with HIV infection (odds ra

112 en groups in absolute waist circumference or waist-to-hip ratio, but waist-to-thigh ratio was smaller

113 fying genetic variants associated with lower waist-to-hip ratio can reveal new therapeutic targets fo

114 Male sex, increased waist to hip ratio, cigarette smoking, increased triglyc

115 irect markers of metabolic disease including waist-to-hip ratio, creatinine, and albumin.

116 Subcutaneous abdominal fat and waist to hip ratio decreased significantly more in the h

117 ith diabetes, higher body mass index, higher waist-to-hip ratio, elevated blood pressure, and inverse

118 I as well as greater waist circumference and waist-to-hip ratio, elevated systolic blood pressure, hi

119 African-American race, higher pulse, higher waist-to-hip ratio, elevated white blood cell count, and

120 ican race, tobacco use, higher pulse, higher waist-to-hip ratio, elevated white blood cell count, his

121 n obesity strata (by body mass index, waist, waist-to-hip ratio, exercise, and dietary fat intake), w

122 ease risk factors, including blood pressure, waist to hip ratio, fasting blood glucose and triglyceri

123 ic measures included body mass index (kg/m2),waist-to-hip ratio, fasting serum high density lipoprote

124 2)), hip circumference, waist circumference, waist-to-hip ratio, fat mass/height(2), lean mass/height

125 ignificant when adjusting for BMI, age, sex, waist-to-hip ratio, fat-cell size, and cardiometabolic d

126 Equation', included age, fS-pIGFBP-1, S-ALT, waist-to-hip ratio, fP-Glucose and fS-Insulin (adjusted

127 8 cm was 3.02 (95% CI, 1.31 to 6.99) and for waist-to-hip ratio > 0.88 was 3.45 (95% CI, 2.02 to 6.92

128 Men with a waist-to-hip ratio > or = 0.99 had a multivariate relati

129 Women in the highest quartile of waist-to-hip ratio had a 61% increased risk of dying fro

130 The body's shape, specifically the waist-to-hip ratio, has been related to perceived attrac

131 nd that of abdominal obesity, as measured by waist-to-hip ratio, have distinct biological backgrounds

132 Allowing for duration, sex, waist-to-hip ratio, HbA1c, systolic blood pressure, and

133 nt of the MI risk score (ie, blood pressure, waist to hip ratio, hemoglobin A1c level, and the ratio

134 r risk groups based on factors that included waist to hip ratio, history of hypertension, hypercholes

135 = 1.66, 95%CI: 1.39-1.99; Ptrend < 0.0001), waist-to-hip ratio (HR = 1.58, 95%CI: 1.31-1.91; Ptrend

136 For women, only waist-to-hip ratio (HR for highest versus lowest fifth =

137 cross-sectionally with age, body mass index, waist-to-hip ratio, hypertension, diabetes, and lipid le

138 actors and odds ratios for obesity, elevated waist-to-hip ratio, hypertension, low levels of high-den

139 adaptation, a theory known generally as the waist-to-hip ratio hypothesis.

140 Waist-to-hip ratio improved more with whey protein (-0.0

141 LPL enhancement were associated with a lower waist-to-hip ratio, improved insulin-glucose metabolism,

142 ted with BMI, total percentage body fat, and waist-to-hip ratio in human subjects.

143 and mean arterial pressure, pulse rate, and waist-to-hip ratio, indicating an association with cardi

144 ly determinants of blood pressure, diabetes, waist-to-hip ratio, inflammatory pathways (IL-6 signalin

145 30 cm [95% CI, -3.27 to -1.33]; P<.001), and waist-to-hip ratio (intervention vs control change: 0.83

146 Furthermore, waist-to-hip ratio is causally related to insulin resist

147 s than 130 mm Hg, no BP-lowering medication, waist-to-hip ratio less than 0.95 for women and less tha

148 for trend < 0.001) compared with men with a waist-to-hip ratio < 0.89.

149 l obesity, most commonly approximated by the waist-to-hip ratio, may be particularly detrimental, alt

150 tion, the fourth quartile group had a higher waist-to-hip ratio; more cholesterol in the very low den

151 ected between schizophrenia and BMI (N=304), waist-to-hip ratio (N=193), smoking initiation (N=293),

152 pressure, age, red cell distribution width, waist-to-hip ratio, neutrophils to lymphocytes ratio, pl

153 iation analyses did not show associations of waist to hip ratio or body mass index between MedDiet ad

154 1.30; 95% CI, 1.00-1.70; P = 0.050), higher waist-to-hip ratio (OR per 0.05 higher, 1.21; 95% CI, 1.

155 (after adjustment for weight and height), 2) waist-to-hip ratio, or 3) principal components analysis.

156 s attenuated after additional adjustment for waist-to-hip ratio (ORHIV, 1.29; 95% CI, .95-1.76).

157 [CI] 1.44-1.70), with comparable results for waist-to-hip ratio (ORSD: 1.63, 95% CI 1.40-1.90) and bo

158 uated after additional adjustment for either waist-to-hip ratio (ORstavudine, 1.30; 95% CI, .85-1.96)

159 was associated with greater BMI (P = 0.02), waist-to-hip ratio (P = 0.01), and waist circumference (

160 nt, had significantly lower BMI (P = 0.017), waist-to-hip ratio (P = 0.013), and, surprisingly, highe

161 r-risk group, waist circumference (P=0.024), waist-to-hip ratio (P<0.001), body mass index (P=0.036),

162 oups did not differ in age, body mass index, waist-to-hip ratio, physical activity index, glycosylate

163 for age, education, hypertension, diabetes, waist-to-hip ratio, physical inactivity, current smoking

164 Body mass index (BMI), waist-to-hip ratio, plasma triglyceride (TRG), total cho

165 minal adiposity, abdominal circumference and waist-to-hip ratio predict the risk of developing gallst

166 dy-fat traits (BMI, body-fat percentage, and waist-to-hip ratio, ranging from 0.96 to 1.00), finding

167 omen, increasing insulin levels and a higher waist-to-hip ratio remained predictors of low levels of

168 ystolic blood pressure, body mass index, and waist-to-hip ratio; respectively.

169 o measure body mass index (BMI; in kg/m(2)), waist-to-hip ratio, sagittal abdominal diameter, and wai

170 y-mass index (BMI), systolic blood pressure, waist-to-hip ratio, serum concentrations of HDL choleste

171 ndrome, including increased body-mass index, waist-to-hip ratio, serum triglyceride levels, and systo

172 ts of age- and sex-adjusted body mass index, waist-to-hip ratio, sex, and PNPLA3 rs738409 polymorphis

173 factors, the combination of systolic BP and waist-to-hip ratio showed the highest area under the rec

174 diposity [BMI, waist circumference (WC), and waist-to-hip ratio] showed little relation with mortalit

175 ective cohort, BMI, waist circumference, and waist-to-hip ratio significantly increased the risks of

176 h CRP after adjustment for age, gender, BMI, waist-to-hip ratio, smoking, and alcohol consumption (F=

177 nificant even after adjustment for age, BMI, waist-to-hip ratio, smoking, and alcohol consumption in

178 ressure (BP), lipid levels, type 2 diabetes, waist-to-hip ratio, smoking, and body mass index with Ce

179 for age, examination year, body mass index, waist-to-hip ratio, smoking, education, physical activit

180 Waist-to-hip ratio, smoking, hypertension, and hyperchol

181 ia showed a strong negative correlation with waist to hip ratio (Spearman's r abdomen -0.986, p<0.000

182 erated an MMS factor that was loaded by BMI, waist-to-hip ratio, subscapular skinfold, triglycerides,

183 oci had differential effects with respect to waist-to-hip ratio, suggesting that the way they influen

184 through ANGPTL4 was associated with a lower waist-to-hip ratio, suggestive of a favorable body fat d

185 ks were independent of age, body mass index, waist-to-hip ratio, systolic blood pressure, serum chole

186 ass index; body weight; waist circumference; waist-to-hip ratio; systolic or diastolic blood pressure

187 confidence interval (CI): 1.05 to 1.12] for waist-to-hip ratio to 1.37 [95% CI: 1.33 to 1.42] for le

188 information on BMI, waist circumference, or waist-to-hip ratio to a cardiovascular disease risk pred

189 brown iris color, hypertension, smoking, and waist-to-hip ratio to be correlated with higher IOP.

190 markers, particularly high WC (>102 cm) and waist-to-hip ratio (top quartile), were associated with

191 s associated with increased fasting insulin, waist-to-hip ratio, triglycerides, and blood pressure, a

192 verlapping loci with lipids, blood pressure, waist-to-hip ratio, type 2 diabetes, and coronary artery

193 BMI, waist-to-hip ratio, waist circumference, and cause-speci

194 mated from anthropometric variables, such as waist-to-hip ratio, waist circumference, or sagittal dia

195 After adjustment for waist-to-hip ratio, waist circumference, or visceral fat

196 sures (body mass index, waist circumference, waist-to-hip ratio, waist-to-height ratio [WHtR]) and ri

197 dex, waist circumference, hip circumference, waist-to-hip ratio, waist-to-height ratio and body fat p

198 Waist-to hip ratio was positively associated with RCC in

199 1.37; I(2)=89%) and per 0.1-unit increase in waist-to-hip ratio was 1.29 (95% confidence interval, 1.

200 Waist-to-hip ratio was also associated with the risk of

201 Comparing highest versus lowest quartile, waist-to-hip ratio was associated with a 1.78-fold incre

202 yses, each 0.06-genetically-predicted higher waist-to-hip ratio was associated with a 29% (1.29; 1.20

203 status, menopausal status, and age, a higher waist-to-hip ratio was associated with a higher risk of

204 In PWH, increase in waist-to-hip ratio was associated with higher kynurenine

205 ese girls, intraabdominal fat but not BMI or waist-to-hip ratio was highly correlated with basal insu

206 The waist-to-hip ratio was inversely related to plasma ascor

207 Central obesity assessed by waist-to-hip ratio was more strongly associated with dia

208 e total variation in HDL cholesterol levels; waist-to-hip ratio was the term that explained the highe

209 ation between S(I) and upper body adiposity (waist-to-hip, ratio) was similar in each ethnic group.

210 diposity, measured by waist circumference or waist-to-hip ratio, was associated with a greater risk o

211 Higher adiposity, particularly higher waist-to-hip ratio, was associated with worse survival.

212 yceride and HDL cholesterol levels, BMI, and waist-to-hip ratio were associated with one factor.

213 Overall, waist circumference and waist-to-hip ratio were not related to PD risk.

214 The associations of mortality with BMI and waist-to-hip ratio were similarly strong, and each was w

215 BMI, waist circumference, and waist-to-hip ratio, whether assessed singly or in combin

216 s: 185.6-177.6 lb [83.5-79.9 kg], P = .001), waist-to-hip ratio (whites: 0.813-0.801, P = .004; black

217 figures varying in body mass index (BMI) and waist to hip ratio (WHR) for short-term and long-term re

218 t ratio (WHtR) of >=0.5 (NWCO by WHtR); 3) a waist to hip ratio (WHR) of >=0.9 in males or >=0.85 in

219 es have examined the association of diet and waist to hip ratio (WHR) with hippocampus connectivity a

220 etrics, such as waist circumference (WC) and waist to hip ratio (WHR), are potentially better indicat

221 Our previous finding that a waist-to-hip ratio (WHR) >0.85 was not associated with s

222 associated with waist circumference (WC) and waist-to-hip ratio (WHR) adjusted for BMI (WCadjBMI and

223 he association of a polygenic risk score for waist-to-hip ratio (WHR) adjusted for body mass index (B

224 alysis of body fat distribution, measured by waist-to-hip ratio (WHR) adjusted for body mass index (W

225 an Ancestry (EA) individuals associated with waist-to-hip ratio (WHR) adjusted for body mass index.

226 BMI), body weight, waist circumference (WC), waist-to-hip ratio (WHR) and abdominal girth (AG).

227 mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR) and metabolic syndrome (MetS) w

228 nship of obesity patterns defined by BMI and waist-to-hip ratio (WHR) and total and cardiovascular mo

229 However, except waist-to-hip ratio (WHR) and waist circumference (WC), i

230 ta were insufficient to pool the results for waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR

231 Body mass index (BMI) and waist-to-hip ratio (WHR) are two widely used anthropomet

232 The cutoffs for waist circumference (WC) and waist-to-hip ratio (WHR) as measures of abdominal adipos

233 We estimated waist-to-hip ratio (WHR) associations with incident clin

234 sting glucose (IFG), insulin resistance, and waist-to-hip ratio (WHR) had effects on cardiac remodeli

235 triglycerides (TG), fasting insulin (FI) and waist-to-hip ratio (WHR) in 4,721 individuals from the N

236 The waist-to-hip ratio (WHR) is one of the most commonly use

237 cumference (WC), hip circumference (HC), and waist-to-hip ratio (WHR) on BCa and PrCa risk.

238 of post-diagnosis body mass index (BMI) and waist-to-hip ratio (WHR) with late all-cause mortality a

239 ons between combined measurements of BMI and waist-to-hip ratio (WHR) with mortality and incident cor

240 MI), waist (WC) and hip (HC) circumferences, waist-to-hip ratio (WHR), %BF, and MRI-measured regional

241 odel, the top five predictive variables were Waist-to-Hip Ratio (WHR), age, waist circumference, trig

242 mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), and computed tomography (CT)-b

243 sociation studies for body mass index (BMI), waist-to-hip ratio (WHR), and multiple cerebrovascular d

244 mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), and specific measures of fat m

245 Body mass index (BMI), waist-to-hip ratio (WHR), and WHR adjusted for BMI were

246 measures of body size, including height and waist-to-hip ratio (WHR), as well as BMI, with cataract.

247 of UNa, body mass index (BMI), BMI-adjusted waist-to-hip ratio (WHR), body fat (BF) percentage and e

248 Waist-to-hip ratio (WHR), body mass index (BMI), systoli

249 r the A1475G variant had significantly lower waist-to-hip ratio (WHR), fasting plasma insulin, and fa

250 After adjusting for age, waist-to-hip ratio (WHR), glycated hemoglobin, smoking,

251 ariate Cox regression analyses detected age, waist-to-hip ratio (WHR), glycosylated haemoglobin (HbA1

252 models predicting body mass index (BMI) and waist-to-hip ratio (WHR), including interaction terms fo

253 allenge adjusted for plasma glucose) on BMI, waist-to-hip ratio (WHR), leg fat, type 2 diabetes (T2D)

254 DNA methylation of individual genes by BMI, waist-to-hip ratio (WHR), or lifetime weight change betw

255 e patterns were similar in models specifying waist-to-hip ratio (WHR), rather than waist circumferenc

256 For the high category of waist-to-hip ratio (WHR), the adjusted odds ratios were

257 Hypertension, waist-to-hip ratio (WHR), triglyceride and HDL cholester

258 ssociated with central adiposity measured as waist-to-hip ratio (WHR), waist circumference (WC) and h

259 ich simple anthropometric measurements [BMI, waist-to-hip ratio (WHR), waist circumference (WC), perc

260 ric surrogates for fat patterning, including waist-to-hip ratio (WHR), waist circumference, subscapul

261 ree different measures of central adiposity: waist-to-hip ratio (WHR), waist-to-height ratio (WSHT),

262 Here, we studied the association between waist-to-hip ratio (WHR), which reflects central adiposi

263 , body weight, waist circumference (WC), and waist-to-hip ratio (WHR).

264 eness: other-rated facial attractiveness and waist-to-hip ratio (WHR).

265 ssociated with a significant increase in the waist-to-hip ratio (WHR).

266 dy mass index (BMI), height and BMI-adjusted waist-to-hip ratio (WHR).

267 nt repeated adiposity [body mass index (BMI)/waist-to-hip ratio (WHR)] measurements over adulthood an

268 marker of general adiposity) independent of waist-to-hip ratio (WHR, a marker of central adiposity)

269 ically predicted effects of BMI (N=806,834), waist-to-hip ratio (WHR; N=697,734) and waist circumfere

270 thropometric (neck and midarm circumference, waist to hip ratio [WHR], and body mass index [BMI] z sc

271 mass index [BMI]; waist circumference [WC]; waist-to-hip ratio [WHR]) and prevalent atherosclerosis

272 resistance (leptin/BMI) and fat patterning (waist-to-hip ratio [WHR]).

273 mference [WC], waist-to-height ratio [WHtR], waist-to-hip ratio [WHR], and waist-to-thigh ratio [WTR]

274 ipants, we test the hypothesis that obesity (waist-to-hip ratio, WHR) is associated with regional dif

275 ept in African American men, and with higher waist-to-hip ratios (WHRs) among African American women.

276 ve associations of percent body fat, WC, and waist-to-hip ratio with NAFLD, with HRs per 1-SD of 2.27

277 y-mass index (BMI), waist circumference, and waist-to-hip ratio with risk of first-onset cardiovascul

278 y (body mass index, waist circumference, and waist-to-hip ratio) with HF risk.

279 ed medical examiners (body mass index (BMI), waist-to-hip ratio (WtH), waist circumference).